Clinical trial

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal…

NCT00409591 · Institut de Recherche pour le Developpement, Other · Terminated

Key facts

NCT number NCT00409591
Title Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand
Official title Maternal and Infant Peripartum Nevirapine, Versus Infant Only Peripartum Nevirapine, or Maternal Lopinavir/Ritonavir in Addition to Standard Zidovudine Prophylaxis for the Prevention of Perinatal HIV in Thailand.
Acronym PHPT-5
Lead sponsor Institut de Recherche pour le Developpement, Other
Collaborators Harvard School of Public Health (HSPH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Terminated
Phase Phase 3
Study type Interventional
Conditions HIV Infections, Pregnancy
Intervention type Drug
Interventions Maternal and infant nevirapine, Maternal placebo and infant nevirapine, Maternal lopinavir+ritonavir, zidovudine
Enrollment 435
Start date Jul 1, 2008
Primary completion Nov 1, 2010
Completion Jun 1, 2015
First posted Dec 11, 2006
Last update posted Jan 28, 2016
Countries Thailand

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies